Why the study?
Do IL-1 inhibitors reduce recurrences in patients with recurrent pericarditis?
Do IL-1 inhibitors reduce recurrences in patients with recurrent pericarditis?
IL-1 inhibitors are effective in reducing recurrences of pericarditis, suggesting they should be incorporated into clinical guidelines for patients with multiple recurrences.
Answers are grounded in this paper and cite their sources.
Supports IL-1 blockade in recurrent pericarditis; leaves open guideline integration pending higher-level confirmation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Vecchié et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: